Innovent Biologics has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for ...

The DaRe2THINK platform – developed by the University of Birmingham and the MHRA's Clinical Practice Research Datalink (CPRD) ...

The federal government shutdown meant that the Securities & Exchange Commission (SEC), which oversees listing processes in ...

Radiopharmaceutical innovator AdvanCell has appointed Andrew Kay as Chair of the Board. Kay previously served as CEO of ...

In a new pharmaphorum podcast, web editor Nicole Raleigh is joined by Piet van der Graaf, Senior VP at Certara – a company ...

The NHS’s Online Hospital ambition signals intent. But to make it real, the focus must move from building a digital replica ...

Rob Milnes (Ultrahuman) connected with pharmaphorum off the Frontiers Health stage to share some insights, following a ...

Direct-to-Patient (DTP) platforms represent a new frontier in patient support services. Properly executed, they help more ...

Donor plasma samples contain information that could lead to massive advances in disease prevention. pharmaphorum grabbed a ...

Medical charity Wellcome has provided £2 million ($2.6 million) in additional funding to the UK's MHRA medicines regulator and reimbursement authority NICE, to help advance the development of digital ...

Following its FDA approval in the summer, Tonix Pharma's fibromyalgia therapy Tonmya has been launched onto the market in the US, becoming the first new drug for the painful condition in more than 16 ...

A clinical trial of Vaderis Therapeutics' AKT inhibitor engasertib suggests it could be the first effective treatment for ...